Past Press Releases - Novacta Biosystems

July 6, 2009
Celtic Pharma Holdings announces investment in Novacta Biosystems Limited
£13.1 million funding to drive novel antibiotics platform addressing areas of major unmet need, including hospital acquired infections C. difficile and MRSA. More

February 24, 2009
Novacta Therapeutics strengthens leadership team
Dr David Pompliano appointed to the Board of Directors and as Chairman of the Scientific Advisory Board More

January 14, 2008
Novacta receives £3.5 million strategic translation award from the Wellcome Trust
Novacta receives £3.5 million strategic translation award from the Wellcome Trust to target C.difficile infections. More

June 14, 2005
NOVACTA BIOSYSTEMS ATTRACTS NEW INVESTMENT
Novacta Biosystems, the Hatfield based biotechnology company, has recently completed an investment round from new and existing investors. The investors, led by Rainbow Seed Fund, include Oxford Technology 4 VCT as well as a number of the existing shareholders, notably GEIF Ventures. Together with the investment from the Wellcome Trust announced in January of this year Novacta has now raised more than €1.4m in the last six months. More